The risk of chronic liver disease and liver-related mortality is increased in patients with type 2 diabetes mellitus. Several cohort studies have suggested a metabolic pathway from nonalcoholic fatty liver, nonalcoholic steatohepatitis, cryptogenic cirrhosis, and eventually hepatocellular carcinoma. Although cardiovascular risk remains the major cause for excess mortality in type 2 diabetes mellitus, the risk of progressive liver disease should no longer be underscored.

E. Bugianesi, E. Vanni, G. Marchesini Reggiani (2007). NASH and the risk of cirrhosis and hepatocellular carcinoma in Type 2 diabetes. CURRENT DIABETES REPORT, 7, 175-180.

NASH and the risk of cirrhosis and hepatocellular carcinoma in Type 2 diabetes

MARCHESINI REGGIANI, GIULIO
2007

Abstract

The risk of chronic liver disease and liver-related mortality is increased in patients with type 2 diabetes mellitus. Several cohort studies have suggested a metabolic pathway from nonalcoholic fatty liver, nonalcoholic steatohepatitis, cryptogenic cirrhosis, and eventually hepatocellular carcinoma. Although cardiovascular risk remains the major cause for excess mortality in type 2 diabetes mellitus, the risk of progressive liver disease should no longer be underscored.
2007
E. Bugianesi, E. Vanni, G. Marchesini Reggiani (2007). NASH and the risk of cirrhosis and hepatocellular carcinoma in Type 2 diabetes. CURRENT DIABETES REPORT, 7, 175-180.
E. Bugianesi; E. Vanni; G. Marchesini Reggiani
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/48738
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 53
  • ???jsp.display-item.citation.isi??? ND
social impact